Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions

Journal of Reproductive Immunology

Volumn 89, Issue 1, 2011, Pages 10-17

  Nelson, Michelle H ^a   Bird, Melanie D ^a   Chu, Chin Fun ^a   Johnson, Alison J ^a   Friedrich, Brian M ^a   Allman, Windy R ^a   Milligan, Gregg N ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

CD8+ t lymphocyte; Cytotoxicity; Female genital tract; Interferon ; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; EFFECTOR CELL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL CLEARANCE;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIUM; FEMALE; GENITALIA, FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERFERON; TH1-TH2 BALANCE; VIRAL LOAD;

EID: 79954988494     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2011.01.013     Document Type: Article

References (31)

1. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., Lederman M.M., Benito J.M., Goepfert P.A., Connors M., Roederer M., Koup R.A. HIV nonprogressors preferentially maintain highly functional, HIV-specific CD8+ T cells. Blood 2006, 107:4781-4789.
2. Bird M.D., Chu C.F., Johnson A.J., Milligan G.N. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J. Virol. 2007, 81:423-426.
3. Cerwenka A., Carter L.L., Reome J.B., Swain S.L., Dutton R.W. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 1998, 161:97-105.
4. Cerwenka A., Morgan T.M., Harmsen A.G., Dutton R.W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 1999, 189:423-434.
5. Cunningham A.L., Diefenbach R.J., Miranda-Saksena M., Bosnjak L., Kim M., Jones C., Douglas M.W. The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis. 2006, 194:S11-18.
6. Dobbs M.E., Strasser J.E., Chu C.F., Chalk C., Milligan G.N. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J. Virol. 2005, 79:14546-14554.
7. Falk K., Rötzschke O., Faath S., Goth S., Graef I., Shastri N., Rammensee H.G. Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL. Cell Immunol. 1993, 150:447-452.
8. Helmich B.K., Dutton R.W. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol. 2001, 166:6500-6508.
9. Johnson A.J., Nelson M.H., Bird M.D., Chu C.F., Milligan G.N. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFNgamma express alternative effector functions but are not protective against genital HSV-2 infection. J. Reprod. Immunol. 2010, 84:8-15.
10. Khanna K.M., Bonneau R.H., Kinchington P.R., Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003, 18:593-603.
11. Khanna K.M., Lepisto A.J., Decman V., Hendricks R.L. Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 2004, 16:463-469.
12. Koelle D.M., Posavad C.M., Barnum G.R., Johnson M.L., Frank J.M., Corey L. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 1998, 101:1500-1508.
13. Koelle D.M., Chen H.B., Gavin M.A., Wald A., Kwok W.W., Corey L. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 2001, 166:4049-4058.
14. Linehan M.M., Richman S., Krummenacher C., Eisenberg R.J., Cohen G.H., Iwasaki A. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J. Virol. 2004, 78:2530-2536.
15. Malkin J.E. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004, 11:2A-23A.
16. Mikloska Z., Cunningham A.L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 2001, 75:11821-11826.
17. Miller L., Patton D.L., Meier A., Thwin S.S., Hooton T.M., Eschenbach D.A. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet. Gynecol. 2000, 96:431-439.
18. Milligan G.N., Bernstein D.I. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 1995, 206:234-241.
19. Milligan G.N., Bernstein D.I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997, 229:259-268.
20. Milligan G.N., Bernstein D.I., Bourne N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 1998, 160:6093-6100.
21. Mosmann T.R., Li L., Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol. 1997, 9:87-92.
22. Parr M.B., Parr E.L. Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunology 2000, 99:540-545.
23. Radosevich T.J., Seregina T., Link C.J. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum. Gene Ther. 2003, 14:1765-1775.
24. Sainz B., Halford W.P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 2002, 76:11541-11550.
25. Simmons A., Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 1992, 175:1337-1344.
26. Svensson A., Bellner L., Magnusson M., Eriksson K. Role of IFNalpha/beta signaling in the prevention of genital herpes virus type 2 infection. J. Reprod. Immunol. 2007, 74:114-123.
27. Tokuriki A., Seo N., Ito T., Kumakiri M., Takigawa M., Tokura Y. Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8 (+) T cells in IP-10 expression. J. Dermatol. Sci. 2002, 28:234-241.
28. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004, 11:24A-35A.
29. Wiley J.A., Cerwenka A., Harkema J.R., Dutton R.W., Harmsen A.G. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 2001, 158:119-130.
30. Woodland D.L., Dutton R.W. Heterogeneity of CD4 (+) and CD8 (+) T cells. Curr. Opin. Immunol. 2003, 15:336-342.
31. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., Berman S.M., Markowitz L.E. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964-973.